44. The Basics of Beta Lactamase Inhibitors
ID:IOTS - Infectious Disease Insight Of Two Specialists
00:00
Discussion on Beta-Lactamase Inhibitors and Their Targets
This chapter provides a comprehensive analysis of different groups of beta-lactamase inhibitors, including their origins, uses, spectrum of activity, and clinical relevance. It covers specific examples such as clavulanic acid, sulbactam, and tazobactam, as well as newer inhibitors like Avabactam and Relebactam. The chapter also discusses mechanisms of resistance and considerations for treatment of ESBLs and AMPCs.
Transcript
Play full episode
